Viking Therapeutics Inc. (VKTX) NASDAQ
$70.42 (7.59) (-9.73%)
Market Cap: $8.60B
As of 05/16/24 03:26 PM EDT. Market open.
Viking Therapeutics Inc. (VKTX)
NASDAQ
$70.42
(7.59) (-9.73%)
Market Cap: $8.60B
As of 05/16/24 03:26 PM EDT. Market open.
Viking Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and endocrine disorders. Their lead clinical program includes drug candidates such as VK2809 and VK0214, which target conditions like non-alcoholic steatohepatitis (NASH) and X-linked adrenoleukodystrophy (X-ALD). They are also working on other programs for metabolic diseases and ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
ZANTE GREG | Chief Financial Officer | May 03, 2024 | Option Exercise | $4.86 | 34,249 | 166,285 | 241,610 | May 03, 2024, 08:51 PM |
ZANTE GREG | Chief Financial Officer | May 03, 2024 | Sale | $74.69 | 66,756 | 4,986,008 | 238,509 | May 03, 2024, 08:51 PM |
Mancini Marianna | Chief Operating Officer | May 01, 2024 | Option Exercise | $6.18 | 281,425 | 1,740,575 | 629,933 | May 02, 2024, 09:27 PM |
Mancini Marianna | Chief Operating Officer | May 01, 2024 | Sale | $78.66 | 281,425 | 22,136,474 | 606,187 | May 02, 2024, 09:27 PM |
Mancini Marianna | Chief Operating Officer | Mar 27, 2024 | Option Exercise | $83.34 | 16,610 | 1,384,277 | 363,565 | Mar 27, 2024, 08:52 PM |
Lian Brian | President & CEO | Mar 27, 2024 | Option Exercise | $83.34 | 153,948 | 12,830,026 | 2,266,453 | Mar 27, 2024, 08:51 PM |
ZANTE GREG | Chief Financial Officer | Mar 27, 2024 | Option Exercise | $83.34 | 16,610 | 1,384,277 | 207,361 | Mar 27, 2024, 08:50 PM |
Lian Brian | President & CEO | Mar 01, 2024 | Option Exercise | $85.22 | 162,815 | 13,875,094 | 2,198,734 | Mar 04, 2024, 07:54 PM |
Mancini Marianna | Chief Operating Officer | Mar 01, 2024 | Option Exercise | $85.22 | 16,958 | 1,445,161 | 348,508 | Mar 04, 2024, 07:52 PM |
ZANTE GREG | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $85.22 | 20,093 | 1,712,325 | 192,304 | Mar 04, 2024, 07:50 PM |
Lian Brian | President & CEO | Feb 09, 2024 | Sale | $29.90 | 45,000 | 1,345,500 | 2,139,882 | Feb 09, 2024, 08:59 PM |
Lian Brian | President & CEO | Feb 08, 2024 | Option Exercise | $3.76 | 189,079 | 711,367 | 2,404,882 | Feb 08, 2024, 07:40 PM |
Lian Brian | President & CEO | Feb 08, 2024 | Sale | $26.87 | 269,079 | 7,230,784 | 2,344,882 | Feb 08, 2024, 07:40 PM |
Rouan Sarah Kathryn | Director | Feb 08, 2024 | Option Exercise | $8.32 | 25,000 | 208,000 | 25,000 | Feb 08, 2024, 07:38 PM |
Rouan Sarah Kathryn | Director | Feb 08, 2024 | Sale | $28.05 | 25,000 | 701,250 | 0 | Feb 08, 2024, 07:38 PM |
Lian Brian | President & CEO | Jan 31, 2024 | Option Exercise | $1.23 | 85,000 | 104,550 | 2,349,882 | Jan 31, 2024, 08:39 PM |
Lian Brian | President & CEO | Jan 31, 2024 | Sale | $24.71 | 85,000 | 2,100,750 | 2,309,882 | Jan 31, 2024, 08:39 PM |
Lian Brian | President & CEO | Jan 30, 2024 | Option Exercise | $1.23 | 35,000 | 43,050 | 2,299,882 | Jan 30, 2024, 09:05 PM |
Lian Brian | President & CEO | Jan 30, 2024 | Sale | $23.95 | 35,000 | 838,250 | 2,264,882 | Jan 30, 2024, 09:05 PM |
Rouan Sarah Kathryn | Director | Jan 19, 2024 | Option Exercise | $8.32 | 30,000 | 249,600 | 30,000 | Jan 19, 2024, 08:35 PM |
Rouan Sarah Kathryn | Director | Jan 19, 2024 | Sale | $23.05 | 30,000 | 691,500 | 0 | Jan 19, 2024, 08:35 PM |
Lian Brian | President & CEO | Jan 04, 2024 | Option Exercise | $18.58 | 39,552 | 734,876 | 2,264,882 | Jan 04, 2024, 09:37 PM |
Lian Brian | President & CEO | Jan 03, 2024 | Option Exercise | $17.40 | 214,640 | 3,734,736 | 2,304,434 | Jan 04, 2024, 09:37 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2024 | Option Exercise | $18.58 | 14,199 | 263,817 | 333,799 | Jan 04, 2024, 09:36 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2024 | Option Exercise | $17.40 | 49,210 | 856,254 | 347,998 | Jan 04, 2024, 09:36 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2024 | Option Exercise | $18.58 | 13,872 | 257,742 | 195,730 | Jan 04, 2024, 09:35 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2024 | Option Exercise | $17.40 | 49,122 | 854,723 | 209,602 | Jan 04, 2024, 09:35 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2024 | Sale | $17.90 | 15,000 | 268,500 | 180,730 | Jan 04, 2024, 09:35 PM |
Rowland Charles A Jr | Director | May 16, 2023 | Option Exercise | $1.08 | 40,000 | 43,200 | 70,000 | May 18, 2023, 06:31 PM |
Rowland Charles A Jr | Director | May 16, 2023 | Sale | $25.00 | 40,000 | 1,000,000 | 30,000 | May 18, 2023, 06:31 PM |
MACARTNEY LAWSON | Director | May 16, 2023 | Option Exercise | $1.19 | 16,000 | 19,040 | 63,965 | May 18, 2023, 06:30 PM |
MACARTNEY LAWSON | Director | May 16, 2023 | Sale | $24.00 | 16,000 | 384,000 | 47,965 | May 18, 2023, 06:30 PM |
Lian Brian | President & CEO | May 01, 2023 | Sale | $22.45 | 45,000 | 1,010,250 | 2,197,963 | May 01, 2023, 07:03 PM |
MACARTNEY LAWSON | Director | Apr 24, 2023 | Option Exercise | $3.33 | 16,000 | 53,280 | 63,965 | Apr 24, 2023, 07:31 PM |
MACARTNEY LAWSON | Director | Apr 24, 2023 | Sale | $22.00 | 16,000 | 352,061 | 47,965 | Apr 24, 2023, 07:31 PM |
Lian Brian | President & CEO | Apr 19, 2023 | Sale | $21.45 | 35,000 | 750,750 | 2,242,963 | Apr 21, 2023, 07:29 PM |
MACARTNEY LAWSON | Director | Apr 17, 2023 | Option Exercise | $8.00 | 20,786 | 166,288 | 68,751 | Apr 18, 2023, 07:10 PM |
MACARTNEY LAWSON | Director | Apr 17, 2023 | Sale | $20.00 | 20,786 | 415,720 | 47,965 | Apr 18, 2023, 07:10 PM |
Lian Brian | President & CEO | Apr 17, 2023 | Option Exercise | $2.15 | 125,000 | 268,750 | 2,432,963 | Apr 18, 2023, 07:09 PM |
Lian Brian | President & CEO | Apr 17, 2023 | Sale | $20.45 | 155,000 | 3,169,765 | 2,277,963 | Apr 18, 2023, 07:09 PM |
Mancini Marianna | Chief Operating Officer | Apr 17, 2023 | Option Exercise | $13.07 | 12,500 | 163,375 | 300,263 | Apr 18, 2023, 07:08 PM |
Mancini Marianna | Chief Operating Officer | Apr 17, 2023 | Sale | $20.00 | 12,500 | 250,000 | 287,763 | Apr 18, 2023, 07:08 PM |
ZANTE GREG | Chief Financial Officer | Apr 17, 2023 | Option Exercise | $13.07 | 7,500 | 98,025 | 156,779 | Apr 18, 2023, 07:07 PM |
ZANTE GREG | Chief Financial Officer | Apr 17, 2023 | Sale | $20.00 | 7,500 | 150,000 | 149,279 | Apr 18, 2023, 07:07 PM |
Lian Brian | President & CEO | Apr 13, 2023 | Option Exercise | $1.88 | 54,336 | 102,152 | 2,387,299 | Apr 13, 2023, 05:14 PM |
Lian Brian | President & CEO | Apr 13, 2023 | Sale | $18.45 | 79,336 | 1,463,749 | 2,307,963 | Apr 13, 2023, 05:14 PM |
ZANTE GREG | Chief Financial Officer | Apr 12, 2023 | Option Exercise | $5.99 | 41,544 | 249,026 | 190,823 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 11, 2023 | Option Exercise | $5.25 | 56,295 | 295,778 | 205,574 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 12, 2023 | Sale | $18.00 | 41,544 | 747,792 | 149,279 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 11, 2023 | Sale | $18.00 | 56,295 | 1,013,518 | 149,279 | Apr 13, 2023, 05:13 PM |
Lian Brian | President & CEO | Apr 03, 2023 | Option Exercise | $17.57 | 200,000 | 3,514,000 | 2,332,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 31, 2023 | Option Exercise | $9.49 | 67,970 | 645,035 | 2,322,933 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 30, 2023 | Option Exercise | $2.42 | 135,382 | 327,838 | 2,408,345 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Apr 03, 2023 | Sale | $17.85 | 22,000 | 392,700 | 2,232,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 31, 2023 | Sale | $17.45 | 67,970 | 1,186,077 | 2,254,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 30, 2023 | Sale | $17.16 | 153,382 | 2,632,516 | 2,320,345 | Apr 03, 2023, 07:26 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $17.57 | 55,166 | 969,267 | 149,279 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $7.77 | 30,911 | 240,178 | 178,689 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Mar 30, 2023 | Option Exercise | $7.29 | 93,750 | 683,483 | 278,807 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Sale | $18.00 | 30,911 | 556,398 | 147,778 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Mar 30, 2023 | Sale | $17.00 | 131,029 | 2,227,821 | 147,778 | Apr 03, 2023, 07:24 PM |
Mancini Marianna | Chief Operating Officer | Mar 30, 2023 | Option Exercise | $17.57 | 30,799 | 541,138 | 287,763 | Apr 03, 2023, 07:22 PM |
Mancini Marianna | Chief Operating Officer | Mar 30, 2023 | Option Exercise | $12.56 | 72,200 | 907,151 | 297,995 | Apr 03, 2023, 07:22 PM |
Mancini Marianna | Chief Operating Officer | Mar 29, 2023 | Option Exercise | $9.13 | 15,000 | 136,950 | 303,137 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 28, 2023 | Option Exercise | $2.37 | 167,427 | 397,193 | 484,700 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 29, 2023 | Sale | $16.00 | 41,242 | 659,872 | 261,895 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 28, 2023 | Sale | $15.00 | 196,563 | 2,948,445 | 288,137 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2023 | Option Exercise | $8.95 | 1,079 | 9,657 | 317,273 | Jan 17, 2023, 07:39 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2023 | Option Exercise | $8.42 | 20,708 | 174,361 | 185,057 | Jan 04, 2023, 06:25 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2023 | Option Exercise | $8.52 | 23,933 | 203,909 | 205,765 | Jan 04, 2023, 06:25 PM |
ZANTE GREG | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $9.40 | 19,697 | 185,152 | 139,031 | Jan 04, 2023, 06:25 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2023 | Option Exercise | $8.42 | 13,994 | 117,829 | 318,352 | Jan 04, 2023, 06:24 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2023 | Option Exercise | $8.52 | 18,854 | 160,636 | 332,346 | Jan 04, 2023, 06:24 PM |
Mancini Marianna | Chief Operating Officer | Dec 30, 2022 | Option Exercise | $9.40 | 12,773 | 120,066 | 260,533 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Jan 04, 2023 | Option Exercise | $8.42 | 28,619 | 240,972 | 2,272,963 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Jan 03, 2023 | Option Exercise | $8.52 | 68,252 | 581,507 | 2,301,582 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Dec 30, 2022 | Option Exercise | $9.40 | 66,127 | 621,594 | 2,103,167 | Jan 04, 2023, 06:24 PM |
FOEHR MATTHEW W | Director | May 02, 2022 | Buy | $2.47 | 45,000 | 111,195 | 111,250 | May 03, 2022, 04:12 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2022 | Option Exercise | $4.24 | 827 | 3,506 | 238,695 | Feb 11, 2022, 06:34 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2022 | Option Exercise | $4.88 | 3,097 | 15,113 | 91,806 | Jan 05, 2022, 07:13 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2022 | Option Exercise | $4.62 | 8,835 | 40,818 | 136,304 | Jan 05, 2022, 07:13 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2022 | Option Exercise | $4.62 | 11,845 | 54,724 | 239,522 | Jan 05, 2022, 07:12 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2022 | Option Exercise | $4.88 | 3,919 | 19,125 | 174,034 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Jan 04, 2022 | Option Exercise | $4.62 | 26,432 | 122,116 | 2,036,686 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Jan 03, 2022 | Option Exercise | $4.88 | 36,319 | 177,237 | 1,889,785 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Sep 28, 2021 | Option Exercise | $6.50 | 27,750 | 180,375 | 1,924,807 | Sep 30, 2021, 05:48 PM |
Mancini Marianna | Chief Operating Officer | Sep 28, 2021 | Option Exercise | $6.50 | 2,839 | 18,454 | 177,535 | Sep 30, 2021, 05:45 PM |
ZANTE GREG | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $6.50 | 2,306 | 14,989 | 94,485 | Sep 30, 2021, 05:43 PM |
FOEHR MATTHEW W | Director | Jun 10, 2021 | Buy | $5.69 | 20,000 | 113,800 | 66,250 | Jun 10, 2021, 04:57 PM |
FOEHR MATTHEW W | Director | Mar 22, 2021 | Option Exercise | $1.50 | 20,000 | 30,000 | 46,250 | Mar 25, 2021, 09:30 PM |
ZANTE GREG | Chief Financial Officer | Jan 19, 2021 | Option Exercise | $6.68 | 808 | 5,397 | 89,751 | Jan 19, 2021, 06:25 PM |
Mancini Marianna | Chief Operating Officer | Jan 19, 2021 | Option Exercise | $6.68 | 994 | 6,640 | 169,952 | Jan 19, 2021, 06:23 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2021 | Option Exercise | $6.48 | 686 | 4,445 | 170,946 | Jan 19, 2021, 06:23 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2021 | Option Exercise | $6.68 | 1,685 | 11,256 | 116,062 | Jan 19, 2021, 06:21 PM |
Lian Brian | President & CEO | Jan 19, 2021 | Option Exercise | $6.68 | 5,611 | 37,481 | 1,894,181 | Jan 19, 2021, 06:19 PM |
Lian Brian | President & CEO | Jan 04, 2021 | Option Exercise | $5.80 | 16,973 | 98,443 | 1,899,792 | Jan 06, 2021, 04:34 PM |
Lian Brian | President & CEO | Jan 03, 2021 | Option Exercise | $5.63 | 31,545 | 177,598 | 1,712,432 | Jan 06, 2021, 04:34 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2021 | Option Exercise | $5.80 | 2,787 | 16,165 | 90,559 | Jan 06, 2021, 04:28 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2021 | Option Exercise | $5.80 | 2,773 | 16,083 | 171,632 | Jan 06, 2021, 04:26 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 04, 2021 | Option Exercise | $5.80 | 2,739 | 15,886 | 117,747 | Jan 06, 2021, 12:00 AM |
MORNEAU MICHAEL | VP, Finance and Administration | Sep 15, 2020 | Option Exercise | $6.25 | 1,557 | 9,731 | 97,873 | Sep 16, 2020, 05:21 PM |
Lian Brian | President & CEO | Sep 15, 2020 | Option Exercise | $6.25 | 19,192 | 119,950 | 1,742,363 | Sep 16, 2020, 05:18 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 26, 2020 | Sale | $8.11 | 148,700 | 1,205,660 | 5,819,383 | Aug 28, 2020, 05:11 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 26, 2020 | Sale | $8.11 | 94,488 | 766,109 | 5,819,383 | Aug 27, 2020, 07:06 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 25, 2020 | Sale | $8.02 | 70,000 | 561,575 | 5,968,083 | Aug 27, 2020, 07:06 PM |
FOEHR MATTHEW W | Director | Jun 30, 2020 | Sale | $7.35 | 13,000 | 95,550 | 26,250 | Jun 30, 2020, 05:54 PM |
Lian Brian | President & CEO | Jan 19, 2020 | Option Exercise | $7.18 | 3,195 | 22,940 | 1,704,312 | Jan 21, 2020, 05:39 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2020 | Option Exercise | $7.18 | 2,044 | 14,676 | 92,840 | Jan 21, 2020, 05:35 PM |
Lian Brian | President & CEO | Jan 03, 2020 | Option Exercise | $7.77 | 6,782 | 52,696 | 1,707,507 | Jan 03, 2020, 08:01 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2019 | Option Exercise | $8.78 | 2,044 | 17,946 | 91,991 | Jan 22, 2019, 07:13 PM |
Lian Brian | President & CEO | Jan 19, 2019 | Option Exercise | $8.78 | 4,333 | 38,044 | 1,560,152 | Jan 22, 2019, 07:13 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Sep 25, 2018 | Sale | $19.15 | 262,881 | 5,034,250 | 6,038,083 | Sep 27, 2018, 09:25 PM |
SINGLETON J MATTHEW | Director | May 31, 2018 | Buy | $9.82 | 9,500 | 93,261 | 9,500 | May 31, 2018, 07:04 PM |
MORNEAU MICHAEL | VP, Finance and Administration | May 31, 2018 | Sale | $9.25 | 21,551 | 199,347 | 94,035 | May 31, 2018, 07:03 PM |
Rowland Charles A Jr | Director | May 29, 2018 | Buy | $5.16 | 30,000 | 154,800 | 30,000 | May 31, 2018, 07:02 PM |
Webster Stephen W | Director | May 29, 2018 | Buy | $5.21 | 8,000 | 41,712 | 8,000 | May 31, 2018, 06:59 PM |
MACARTNEY LAWSON | Director | May 29, 2018 | Buy | $5.22 | 47,965 | 250,329 | 47,965 | May 31, 2018, 06:57 PM |
MORNEAU MICHAEL | VP, Finance and Administration | May 04, 2018 | Option Exercise | $4.22 | 7,616 | 32,140 | 94,035 | May 08, 2018, 08:37 PM |
Lian Brian | President & CEO | May 04, 2018 | Option Exercise | $4.22 | 10,086 | 42,563 | 1,483,012 | May 08, 2018, 08:37 PM |
MORNEAU MICHAEL | Chief Financial Officer | May 04, 2017 | Option Exercise | $1.34 | 8,192 | 10,977 | 80,604 | May 05, 2017, 06:25 PM |
FOEHR MATTHEW W | Director | Nov 15, 2016 | Buy | $1.21 | 13,000 | 15,678 | 39,250 | Nov 15, 2016, 04:34 PM |
Hanley Rochelle | Chief Medical Officer | May 04, 2016 | Option Exercise | $1.31 | 10,595 | 13,879 | 160,836 | May 05, 2016, 05:36 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Apr 13, 2016 | Option Exercise | $1.25 | 960,000 | 1,200,000 | 6,300,964 | Apr 15, 2016, 05:19 PM |
FOEHR MATTHEW W | Director | Apr 13, 2016 | Buy | $1.24 | 20,000 | 24,800 | 26,250 | Apr 13, 2016, 06:17 PM |
Lian Brian | President & CEO | May 04, 2015 | Option Exercise | $9.49 | 16,346 | 155,124 | 1,453,098 | May 06, 2015, 08:20 PM |
Dinerman Michael | Chief Operating Officer | May 04, 2015 | Option Exercise | $9.49 | 8,724 | 82,791 | 694,116 | May 06, 2015, 08:19 PM |
MORNEAU MICHAEL | Chief Financial Officer | May 04, 2015 | Option Exercise | $9.49 | 10,404 | 98,734 | 77,404 | May 06, 2015, 07:20 PM |
Hanley Rochelle | Chief Medical Officer | May 04, 2015 | Option Exercise | $9.49 | 7,308 | 69,353 | 168,855 | May 06, 2015, 07:18 PM |
FOEHR MATTHEW W | Director | May 04, 2015 | Buy | $8.00 | 6,250 | 50,000 | 6,250 | May 05, 2015, 01:47 PM |
Owner | Relationship | Date | Value($) |
ZANTE GREG | Chief Financial Officer | 05/03/2024 | 166,285 |
ZANTE GREG | Chief Financial Officer | 05/03/2024 | 4,986,008 |
Mancini Marianna | Chief Operating Officer | 05/01/2024 | 1,740,575 |
Mancini Marianna | Chief Operating Officer | 05/01/2024 | 22,136,474 |
Mancini Marianna | Chief Operating Officer | 03/27/2024 | 1,384,277 |
Lian Brian | President & CEO | 03/27/2024 | 12,830,026 |
ZANTE GREG | Chief Financial Officer | 03/27/2024 | 1,384,277 |
Lian Brian | President & CEO | 03/01/2024 | 13,875,094 |
Mancini Marianna | Chief Operating Officer | 03/01/2024 | 1,445,161 |
ZANTE GREG | Chief Financial Officer | 03/01/2024 | 1,712,325 |
Lian Brian | President & CEO | 02/09/2024 | 1,345,500 |
Lian Brian | President & CEO | 02/08/2024 | 711,367 |
Lian Brian | President & CEO | 02/08/2024 | 7,230,784 |
Rouan Sarah Kathryn | Director | 02/08/2024 | 208,000 |
Rouan Sarah Kathryn | Director | 02/08/2024 | 701,250 |
Lian Brian | President & CEO | 01/31/2024 | 104,550 |
Lian Brian | President & CEO | 01/31/2024 | 2,100,750 |
Lian Brian | President & CEO | 01/30/2024 | 43,050 |
Lian Brian | President & CEO | 01/30/2024 | 838,250 |
Rouan Sarah Kathryn | Director | 01/19/2024 | 249,600 |
Rouan Sarah Kathryn | Director | 01/19/2024 | 691,500 |
Lian Brian | President & CEO | 01/04/2024 | 734,876 |
Lian Brian | President & CEO | 01/03/2024 | 3,734,736 |
Mancini Marianna | Chief Operating Officer | 01/04/2024 | 263,817 |
Mancini Marianna | Chief Operating Officer | 01/03/2024 | 856,254 |
ZANTE GREG | Chief Financial Officer | 01/04/2024 | 257,742 |
ZANTE GREG | Chief Financial Officer | 01/03/2024 | 854,723 |
ZANTE GREG | Chief Financial Officer | 01/04/2024 | 268,500 |
Rowland Charles A Jr | Director | 05/16/2023 | 43,200 |
Rowland Charles A Jr | Director | 05/16/2023 | 1,000,000 |
MACARTNEY LAWSON | Director | 05/16/2023 | 19,040 |
MACARTNEY LAWSON | Director | 05/16/2023 | 384,000 |
Lian Brian | President & CEO | 05/01/2023 | 1,010,250 |
MACARTNEY LAWSON | Director | 04/24/2023 | 53,280 |
MACARTNEY LAWSON | Director | 04/24/2023 | 352,061 |
Lian Brian | President & CEO | 04/19/2023 | 750,750 |
MACARTNEY LAWSON | Director | 04/17/2023 | 166,288 |
MACARTNEY LAWSON | Director | 04/17/2023 | 415,720 |
Lian Brian | President & CEO | 04/17/2023 | 268,750 |
Lian Brian | President & CEO | 04/17/2023 | 3,169,765 |
Mancini Marianna | Chief Operating Officer | 04/17/2023 | 163,375 |
Mancini Marianna | Chief Operating Officer | 04/17/2023 | 250,000 |
ZANTE GREG | Chief Financial Officer | 04/17/2023 | 98,025 |
ZANTE GREG | Chief Financial Officer | 04/17/2023 | 150,000 |
Lian Brian | President & CEO | 04/13/2023 | 102,152 |
Lian Brian | President & CEO | 04/13/2023 | 1,463,749 |
ZANTE GREG | Chief Financial Officer | 04/12/2023 | 249,026 |
ZANTE GREG | Chief Financial Officer | 04/11/2023 | 295,778 |
ZANTE GREG | Chief Financial Officer | 04/12/2023 | 747,792 |
ZANTE GREG | Chief Financial Officer | 04/11/2023 | 1,013,518 |
Lian Brian | President & CEO | 04/03/2023 | 3,514,000 |
Lian Brian | President & CEO | 03/31/2023 | 645,035 |
Lian Brian | President & CEO | 03/30/2023 | 327,838 |
Lian Brian | President & CEO | 04/03/2023 | 392,700 |
Lian Brian | President & CEO | 03/31/2023 | 1,186,077 |
Lian Brian | President & CEO | 03/30/2023 | 2,632,516 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 969,267 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 240,178 |
ZANTE GREG | Chief Financial Officer | 03/30/2023 | 683,483 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 556,398 |
ZANTE GREG | Chief Financial Officer | 03/30/2023 | 2,227,821 |
Mancini Marianna | Chief Operating Officer | 03/30/2023 | 541,138 |
Mancini Marianna | Chief Operating Officer | 03/30/2023 | 907,151 |
Mancini Marianna | Chief Operating Officer | 03/29/2023 | 136,950 |
Mancini Marianna | Chief Operating Officer | 03/28/2023 | 397,193 |
Mancini Marianna | Chief Operating Officer | 03/29/2023 | 659,872 |
Mancini Marianna | Chief Operating Officer | 03/28/2023 | 2,948,445 |
Mancini Marianna | Chief Operating Officer | 01/15/2023 | 9,657 |
ZANTE GREG | Chief Financial Officer | 01/04/2023 | 174,361 |
ZANTE GREG | Chief Financial Officer | 01/03/2023 | 203,909 |
ZANTE GREG | Chief Financial Officer | 12/30/2022 | 185,152 |
Mancini Marianna | Chief Operating Officer | 01/04/2023 | 117,829 |
Mancini Marianna | Chief Operating Officer | 01/03/2023 | 160,636 |
Mancini Marianna | Chief Operating Officer | 12/30/2022 | 120,066 |
Lian Brian | President & CEO | 01/04/2023 | 240,972 |
Lian Brian | President & CEO | 01/03/2023 | 581,507 |
Lian Brian | President & CEO | 12/30/2022 | 621,594 |
FOEHR MATTHEW W | Director | 05/02/2022 | 111,195 |
Mancini Marianna | Chief Operating Officer | 01/15/2022 | 3,506 |
ZANTE GREG | Chief Financial Officer | 01/03/2022 | 15,113 |
ZANTE GREG | Chief Financial Officer | 01/04/2022 | 40,818 |
Mancini Marianna | Chief Operating Officer | 01/04/2022 | 54,724 |
Mancini Marianna | Chief Operating Officer | 01/03/2022 | 19,125 |
Lian Brian | President & CEO | 01/04/2022 | 122,116 |
Lian Brian | President & CEO | 01/03/2022 | 177,237 |
Lian Brian | President & CEO | 09/28/2021 | 180,375 |
Mancini Marianna | Chief Operating Officer | 09/28/2021 | 18,454 |
ZANTE GREG | Chief Financial Officer | 09/28/2021 | 14,989 |
FOEHR MATTHEW W | Director | 06/10/2021 | 113,800 |
FOEHR MATTHEW W | Director | 03/22/2021 | 30,000 |
ZANTE GREG | Chief Financial Officer | 01/19/2021 | 5,397 |
Mancini Marianna | Chief Operating Officer | 01/19/2021 | 6,640 |
Mancini Marianna | Chief Operating Officer | 01/15/2021 | 4,445 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2021 | 11,256 |
Lian Brian | President & CEO | 01/19/2021 | 37,481 |
Lian Brian | President & CEO | 01/04/2021 | 98,443 |
Lian Brian | President & CEO | 01/03/2021 | 177,598 |
ZANTE GREG | Chief Financial Officer | 01/04/2021 | 16,165 |
Mancini Marianna | Chief Operating Officer | 01/04/2021 | 16,083 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/04/2021 | 15,886 |
MORNEAU MICHAEL | VP, Finance and Administration | 09/15/2020 | 9,731 |
Lian Brian | President & CEO | 09/15/2020 | 119,950 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/26/2020 | 1,205,660 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/26/2020 | 766,109 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/25/2020 | 561,575 |
FOEHR MATTHEW W | Director | 06/30/2020 | 95,550 |
Lian Brian | President & CEO | 01/19/2020 | 22,940 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2020 | 14,676 |
Lian Brian | President & CEO | 01/03/2020 | 52,696 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2019 | 17,946 |
Lian Brian | President & CEO | 01/19/2019 | 38,044 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 09/25/2018 | 5,034,250 |
SINGLETON J MATTHEW | Director | 05/31/2018 | 93,261 |
MORNEAU MICHAEL | VP, Finance and Administration | 05/31/2018 | 199,347 |
Rowland Charles A Jr | Director | 05/29/2018 | 154,800 |
Webster Stephen W | Director | 05/29/2018 | 41,712 |
MACARTNEY LAWSON | Director | 05/29/2018 | 250,329 |
MORNEAU MICHAEL | VP, Finance and Administration | 05/04/2018 | 32,140 |
Lian Brian | President & CEO | 05/04/2018 | 42,563 |
MORNEAU MICHAEL | Chief Financial Officer | 05/04/2017 | 10,977 |
FOEHR MATTHEW W | Director | 11/15/2016 | 15,678 |
Hanley Rochelle | Chief Medical Officer | 05/04/2016 | 13,879 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 04/13/2016 | 1,200,000 |
FOEHR MATTHEW W | Director | 04/13/2016 | 24,800 |
Lian Brian | President & CEO | 05/04/2015 | 155,124 |
Dinerman Michael | Chief Operating Officer | 05/04/2015 | 82,791 |
MORNEAU MICHAEL | Chief Financial Officer | 05/04/2015 | 98,734 |
Hanley Rochelle | Chief Medical Officer | 05/04/2015 | 69,353 |
FOEHR MATTHEW W | Director | 05/04/2015 | 50,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 8,274,174 | 0.02% | 8.79% | Other |
VIKING GLOBAL INVESTORS LP | 1,094,940 | 0.33% | -78.72% | Growth At A Reasonable Price |
GEODE CAPITAL MANAGEMENT, LLC | 2,326,779 | 0.02% | 9.32% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 108,595 | 0.02% | -95.16% | Event Driven |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 463,501 | 0.66% | -63.76% | Other |
BAMCO INC /NY/ | 493,259 | 0.11% | 59.08% | Growth At A Reasonable Price |
BALYASNY ASSET MANAGEMENT L.P. | 125,000 (Call) | 0.00437% | Exited | Event Driven |
D. E. SHAW & CO., INC. | 75,742 | 0.00532% | -34.5% | Other |
ALPS ADVISORS INC | 74,007 | 0.04% | 11.49% | Other |
STEADFAST CAPITAL MANAGEMENT LP | 52,000 | 0.1% | New | Growth At A Reasonable Price |
D. E. SHAW & CO., INC. | 50,000 (Call) | 0.00351% | New | Other |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 50,000 (Call) | 0.03% | New | Value |
AQR CAPITAL MANAGEMENT LLC | 39,890 | 0.00557% | -15.95% | Other |
ROYCE & ASSOCIATES LP | 6,951 | 0.00509% | -75.21% | Value |
TUDOR INVESTMENT CORP ET AL | 25,700 (Call) | 0.01% | New | Event Driven, Other |
UBS OCONNOR LLC | 22,141 | 0.02% | Exited | Value |
TUDOR INVESTMENT CORP ET AL | 9,800 (Put) | 0.00511% | New | Event Driven, Other |
HARVEST MANAGEMENT LLC | 4,000 | 0.22% | New | Event Driven |
Period of Report: 03/31/2024
10-K/10-Q Filings: View